Table 4.
Association between developed PJI, study group, and medical data.
| PJI in Screening Group I (n = 4) | PJI in Comparison Group II (n = 6) |
p-Value | ||
|---|---|---|---|---|
| Age in years (mv ± sd) | 73.00 ± 8.79 | 68.83 ± 6.71 | 0.522 | |
| Gender (male in %, (n)) | 50% (2) | 100% (6) | 0.053 | |
| Prosthesis % (n) | THR | 75% (3) | 66.7% (4) | 0.778 |
| TKR | 25% (1) | 33.3% (2) | ||
| Sledge | 0% (0) | 0% (0) | ||
| Status of wound % (n) | unremarkable | 100% (4) | 83.3% (5) | 0.389 |
| Pico | 0% (0) | 16.7% (1) | ||
| Staph. Epidermis | 75% (3) | 16.7% (1) | 0.076 | |
| Staph. aureus | 0% (0) | 66.7% (4) | ||
| Germ detection | Staph Epidermis + Staph Capitis | 0% (0) | 16.7% (1) | |
| HWI, actinobacter pittii (subcutan) | 25% (1) | 0% (0) | ||
| Diabetes mellitus II (yes in %, (n)) | 25% (1) | 33.3% (2) | 0.778 | |
| Smoking habits (smoker in %, (n)) | 0% (0) | 0% (0) | ||
| BMI (kg/m2; mv ± sd) |
27.50 ± 3.42 | 33.67 ± 5.68 | 0.084 | |
| CRP at inpatient discharge (mg/L; mv ± sd) | 107.25 ± 61.18 | 170.33 ± 94.22 | 0.286 |
mv: mean value, sd: standard deviation.